Therapeutic agent with quantitative consumption marker
US6136801A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Dec 24, 1998 |
| Grant date | Oct 24, 2000 |
| Priority date | — |
| Expiry date | Dec 24, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/174614
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Quantitative compliance markers and associated methods for monitoring patient compliance with medication prescriptions associated with compliance markers have been found to eliminate the need for specific quantitative relationships for each new drug tested. Such compliance markers and methods for monitoring patient compliance utilize pharmacologically inert substances, namely the weak acids benzodiazepines, or non-metabolizable substances in association with an underlying drug at a measurable dosage, so as to correlate compliance marker concentration with underlying medication concentration to determine amount of actual medication ingested.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.